Medizinische Klinik III, Schwerpunkt Hämatologie, Onkologie und Palliativmedizin
Dorstenerstr. 151
45657 Recklinghausen
Fax: 02361-56-3398
Mail: ed.tsev-mukinilk@eigolokno
Medical administration
Dr. med. Michael Klein (Chefarzt)
Information and services of the department
- Number of inpatient cases: 659
- Medical expertiseSpecialist training and additional training
- Nursing expertiseFurther education / academic degrees and additional qualifications
Services search (in the department)
| Illness | Number of cases |
|---|---|
| Non-follicular lymphoma (C83.3) | 51 |
| Malignant neoplasm of bronchus and lung (C34.1) | 44 |
| Malignant neoplasm of bronchus and lung (C34.3) | 43 |
| Malignant neoplasm of brain - Malignant neoplasm of temporal lobe (C71.2) | 28 |
| Myeloid leukaemia - Acute myeloblastic leukemia not having achieved remission (C92.00) | 25 |
| Malignant neoplasm of colon - Malignant neoplasm of ascending colon (C18.2) | 24 |
| Malignant neoplasm of bronchus and lung (C34.8) | 24 |
| Multiple myeloma and malignant plasma cell neoplasms - Multiple myeloma not having achieved remission (C90.00) | 16 |
| Malignant neoplasm without specification of site - Disseminated malignant neoplasm unspecified (C80.0) | 13 |
| Non-follicular lymphoma (C83.0) | 10 |
| Treatment | Number |
|---|---|
| (9-984.7) | 166 |
| Cancer treatment for one or more days with chemotherapy drugs administered into a vein or beneath the skin (8-542.11) | 145 |
| Transfusion of blood, red blood cells or platelets from a donor to a recipient (8-800.c0) | 136 |
| (9-984.8) | 105 |
| Administration of medicines in accordance with List 2 of the procedures list (6-002.72) | 73 |
| Cancer treatment for one or more days with chemotherapy drugs administered into a vein or beneath the skin (8-542.12) | 64 |
| Others therapeutic procedures to influence the immune system (8-547.31) | 58 |
| Others therapeutic procedures to influence the immune system (8-547.30) | 54 |
| Taking a tissue sample (biopsy) of the bone marrow without surgical incision (1-424) | 50 |
| Cancer treatment for several days (e.g. 2-4 days) with two or more chemotherapy drugs administered into a vein (8-543.13) | 50 |
Hospital information and services for all specialist departments
Further information
- External quality assurance according to state law
No participation
Chronische obstruktive Lungenerkrankung (COPD)
| No. | Explanation |
|---|---|
| CQ01 |
| Number | Group |
|---|---|
| 86 | Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training* |
| 40 | Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence |
| 38 | Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations |
| Job | Explanation |
|---|---|
| Lectureships / teaching posts at colleges and universities | Diverse Dozenturen/ Lehrbeauftragungen, siehe Auflistung unten |
| Lectureships / teaching posts at universities of applied sciences | |
| Student training (clinical traineeship / internship year) | Lehrbeauftragte und apl. Professuren an der Universität Bochum |
| Project-related cooperation with colleges and universities | Prof. Dr. Szeimies: Leitlinienkonferenzen der DKG aktinische Keratosen und spinozelluläres Karzinom der Haut, EADO Basalzellkarzinom; Projekt Wilh.-Sander-Stiftung: Kombinationstherapie von kaltem atmosphärischem Plasma und Photodynamischer Therapie Verbesserung der Behandlung aktinischer Keratosen |
| Participation in multi-centre Phase I/II studies | Teilnahme an Leitlinienkonferenzen der Deutschen Gesellschaft für Verdauungs- und Stoffwechselkrankheiten (DGVS) Virushepatitis B und C sowie kolorektaler Karzinom |
| Participation in multi-centre phase III/IV studies | Prof. Dr. med. Hilker-Roggendorf: Teilnahme PRODAST-Studie (Orale Antikoagulation nach Schlaganfall), SWIFT-DIRECT Studie (Thrombektomie bei akutem Schlaganfall) |
| Initiation and management of uni-centric/multi-centric clinical/scientific studies | Prof. Dr. med. Rolf-Markus Szeimies: nationale und internationale Studienleitung bei 2 uni- und multizentrischen Studien zur Behandlung von hellem Hautkrebs und Vorstufen |
| Editors of scientific journals/textbooks | Klinische Neurophysiologie Neurolab Prof. Dr. med. Rolf-Markus Szeimies: Herausgeber „Der Hautarzt“; Editorial Board „Photodermatology, Photoimmunology & Photomedicine“ |
| Doctoral supervision | Prof. Dr. Szeimies: Gesundheitsprävention bei Berufstätigen mit Außenarbeitsplätzen - eine Längsschnittstudie über die Wirkung einer Schulungsmaßnahme zum UV-bedingten Hautkrebs und Lichtschutz (Dr. med. Frank Moschner-Kunert) |
| No. | Training in other healing professions | Comment |
|---|---|---|
| HB01 | Nurse and health care worker (m/f) | Theoretische und praktische Ausbildung |
| HB03 | Physical therapist / physiotherapist (m/f) | Praktische Ausbildung |
| HB05 | Medical technical radiology assistant (MTRA) (m/f) | Theoretische und praktische Ausbildung |
| HB07 | Surgical technical assistant (m/f) | Ausbildung |
| HB17 | Auxiliary nurse (m/f) | Theoretische und praktische Ausbildung |
| HB15 | Anaesthesia technical assistant (m/f) | Ausbildung |
| HB19 | Nursing professionals | Theoretische und praktische Ausbildung |
Heinz Schulz
Patientenfürsprecher
Dorstenerstr. 151
45657 Recklinghausen
Phone:
02361
-47993-
Mail:
ed.tsev-mukinilk@edrewhcseb
Erdal Öztürk
Rückmeldemanager
Dorstenerstr. 151
45657 Recklinghausen
Phone:
02361
-56-81090
Mail:
ed.tsev-mukinilk@tnemeganamedlemkceur
Ingrid Rotert-Hansen
Leitung Qualitäts- und Risikomanagement
Dorstenerstr. 151
45657 Recklinghausen
Phone:
02361
-56-1005
Mail:
ed.tsev-mukinilk@nesnah-tretor.dirgni
Prof. Dr. med. Hans Georg Bone
Ärztlicher Direktor
Dorstenerstr. 151
45657 Recklinghausen
Phone:
02361
-56-3001
Mail:
ed.tsev-mukinilk@enob.groeg-snah
Prof. Dr. med. Hans Georg Bone
Ärztlicher Direktor
Dorstenerstr. 151
45657 Recklinghausen
Phone:
02361
-56-3001
Mail:
ed.tseV-mukinilK@enoB.groeG-snaH